Results revealed that in some PCa patients with a higher grade or higher Gleason score of PCa, their lnc-OPHN1-5 expressions were decreased after ADT (three of seven patients decreased, Fig. S3E and Table S3), and in contrast, in some PCa patients with a lower grade or lower Gleason score of PCa, their lnc-OPHN1-5 expressions were increased after ADT (four of seven patients increased, Fig. S3E), indicating that ADT efficacy might be linked with lnc-OPHN1-5 expression. The gene discussed is OPHN1; the disease is posterior cortical atrophy.